Production of kappa-caseino-glycomacropeptide

Details Production of kappa-caseino-glycomacropeptide Production of kappa-caseino-glycomacropeptide

1991-03-21

1993-06-01

Russel, Jeffery E.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Casein or caseinate

530407, 530395, C07K 1514, C07K 324

Patent

active

052161293

ABSTRACT:
Kappa-caseino-glycomacropeptide (CGMP) is industrially produced from a whey product concentrated in proteins partly freed from lactose by selective precipitation of the residual whey proteins with ethanol from the supernatant collected after separation of the flocculate obtained by heat treatment in acidic medium.

REFERENCES:
patent: 4042575 (1977-08-01), Eustache
patent: 4042576 (1977-08-01), Eustache
patent: 4994441 (1991-02-01), Neeser
patent: 5061622 (1991-10-01), Dosako et al.
Zittle and Custer, Journal of Dairy Science, Nov. 1963, vol. XLVI, No. 11, pp. 1183-1188.
McKenzie and Wake, An Improved Method for the Isolation of .sub.k -Casein, Biochem. Biophys Acta 47:240, 1961.

Affiliated with

Also associated with

Rating

Production of kappa-caseino-glycomacropeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Production of kappa-caseino-glycomacropeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of kappa-caseino-glycomacropeptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1815815